Viking touts once-a-month weight loss maintenance data
Viking Therapeutics says patients who switched to a once-a-month dosing regimen of its obesity drug did not regain much weight after 12 weeks, bolstering the potential of a less frequent schedule. The company, which is ...
We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.